Blog

Jul 17, 2025, 16:12

Aneel Bhangu: Surgical Health Policy 2025–35

Aneel Bhangu, Professor of Global Surgery at University of Birmingham, shared a post on LinkedIn about recent article by Dmitri Nepogodiev et al., published on The Lancet.

“Surgical health policy 2025–35

10 years on from the Lancet Commission on Global Surgery, a lot has happened. Here, we benchmark progress using data and give an overview of the future.

1. 160 million operations remain unmet each year, mostly in low- and middle-income countries.
2. Around 3.5 million adults die within 30 days after surgery annually – more than deaths from HIV, malaria and tuberculosis combined.
3. Surgical investment strengthens whole hospitals, including diagnostics, oxygen supply, energy security and critical-care capacity.
4. Scaling up essential cancer surgery in LMICs could add over US $80 billion a year in productivity and return roughly 885 000 people to work.
5. COVID-19 exposed fragile systems: 28 million operations were cancelled in 12 weeks; stronger preparedness is needed against pandemics, climate events, and war.

There’s a lot still to cover. Please write letters back to the Lancet, highlighting what you agree with, disagree with, or wish to add towards.”

Title: Surgical health policy 2025–35: strengthening essential services for tomorrow’s needs

Authors: Dmitri Nepogodiev, Maria Picciochi, Adesoji Ademuyiwa, Adewale Adisa, Anita E Agbeko, Maria-Lorena Aguilera, Fareeda Agyei, Philip Alexander, Jaymie Henry, Theophilus T K Anyomih, Alazar B Aregawi, Rifat Atun, Bruce Biccard, Mumba Chalwe, Kathryn Chu, Arri Coomarasamy, Richard Crawford, Ara Darzi, Justine Davies, Zipporah Gathuya, Aneel Bhangu

Read The Full Article at The Lancet.

Aneel Bhangu: Surgical Health Policy 2025–35

More Posts Featuring Health.

Adesoji Ademuyiwa Adewale Adisa Alazar B Aregawi Aneel Bhangu Anita E Agbeko Ara Darzi Arri Coomarasamy Bruce Biccard cancer Dmitri Nepogodiev Fareeda Agyei health Jaymie Henry Justine Davies Kathryn Chu Lancet Commission on Global Surgery Maria Picciochi Maria-Lorena Aguilera Mumba Chalwe OncoDaily Oncology Philip Alexander Richard Crawford Rifat Atun Surgical Health Surgical Health Policy Theophilus T K Anyomih Zipporah Gathuya

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Yüksel Ürün: Science Is Better When It’s Shared